← Leaderboards
Ken Fujise
University Of Washington
$10,354,033
Attributed
$14,324,747
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$14,324,747 · 7
By mechanism
R01$13,520,266 · 5
K08$498,744 · 1
R41$305,737 · 1
Top collaborators
- Shiyou Chen4 shared
- Qingjie Li4 shared
- Sanjay Srivastava4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Monica Yicette Sanchez-Contreras$777,131
- Karin E. Bornfeldt$36,322,585
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisProteinsPreventCellsCell PhysiologyGeneticAmino AcidsPhenotypeCoronary ArteriosclerosisCytosolApplications GrantsTpt1 GeneBindingBaseAmericanMacrophageAtherosclerosisInflammatoryAnimalsGenesMediatingMolecularKnock-OutKnockout Mice
Grant awards (33)
Fortilin, CTNNA3, and the Heart$660,031
R01 · FY2024 · HL · contact PI
Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention$152,749
R41 · FY2024 · HL · contact PI
Cellular and Circulating Fortilin in Vascular Diseases$681,922
R01 · FY2023 · HL · contact PI
Fortilin, CTNNA3, and the Heart$666,266
R01 · FY2023 · HL · contact PI
Gut Dysbiosis and Cardiac Remodeling in IBD$634,956
R01 · FY2023 · HL
Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention$152,988
R41 · FY2023 · HL · contact PI
Cellular and Circulating Fortilin in Vascular Diseases$683,899
R01 · FY2022 · HL · contact PI
Fortilin, CTNNA3, and the Heart$659,176
R01 · FY2022 · HL · contact PI
Gut Dysbiosis and Cardiac Remodeling in IBD$643,457
R01 · FY2022 · HL
Fortilin, CTNNA3, and the Heart$709,280
R01 · FY2021 · HL · contact PI
Cellular and Circulating Fortilin in Vascular Diseases$683,899
R01 · FY2021 · HL · contact PI
Gut Dysbiosis and Cardiac Remodeling in IBD$649,903
R01 · FY2021 · HL
Cellular and Circulating Fortilin in Vascular Diseases$718,619
R01 · FY2020 · HL · contact PI
Gut Dysbiosis and Cardiac Remodeling in IBD$653,505
R01 · FY2020 · HL
USING FORTILIN INHIBITORS TO BLOCK ATHEROSCLEROSIS$542,463
R01 · FY2020 · HL · contact PI
Using Fortilin Inhibitors to Block Atherosclerosis$667,812
R01 · FY2019 · HL · contact PI
Using Fortilin Inhibitors to Block Atherosclerosis$668,783
R01 · FY2018 · HL · contact PI
Using Fortilin Inhibitors to Block Atherosclerosis$712,211
R01 · FY2017 · HL · contact PI
Fortilin, p53, and atherosclerosis$382,500
R01 · FY2017 · HL · contact PI
Fortilin, p53, and atherosclerosis$382,500
R01 · FY2016 · HL · contact PI
Fortilin, p53, and atherosclerosis$376,762
R01 · FY2015 · HL · contact PI
Fortilin, p53, and atherosclerosis$374,850
R01 · FY2014 · HL · contact PI
Fortilin, p53, and atherosclerosis$375,610
R01 · FY2013 · HL · contact PI
Characterization of Fortilin, A Novel Anti-p53 Protein$44,550
R01 · FY2005 · HL
Characterization of Fortilin, A Novel Anti-p53 Protein$267,361
R01 · FY2004 · HL
Characterization of Fortilin, A Novel Anti-p53 Protein$7,201
R01 · FY2004 · HL
Characterization of Fortilin, A Novel Anti-p53 Protein$224,250
R01 · FY2003 · HL
MOLECULAR CHARACTERIZATION OF MCLI PCNA INTERACTION$124,686
K08 · FY2003 · HL
Characterization of Fortilin, A Novel Anti-p53 Protein$224,250
R01 · FY2002 · HL
MOLECULAR CHARACTERIZATION OF MCLI PCNA INTERACTION$124,686
K08 · FY2002 · HL
Characterization of Fortilin, A Novel Anti-p53 Protein$224,250
R01 · FY2001 · HL
MOLECULAR CHARACTERIZATION OF MCLI PCNA INTERACTION$124,686
K08 · FY2001 · HL
MOLECULAR CHARACTERIZATION OF MCLI PCNA INTERACTION$124,686
K08 · FY2000 · HL